StoxNarayana Hrudayalaya vs Global Health: share price & financials comparison
NSE: NH vs MEDANTA · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Narayana Hrudayalaya vs Global Health at a glance
Narayana Hrudayalaya (NH) has a market capitalisation of ₹38,890 Cr, against ₹37,281 Cr for Global Health (MEDANTA). Over the past year Narayana Hrudayalaya has returned +5.7%, compared with +0.9% for Global Health. On valuation, Narayana Hrudayalaya trades at a lower P/E of 45.3 versus 93.7. Narayana Hrudayalaya earns a higher return on equity (17.2% vs 9.2%). Narayana Hrudayalaya comes out ahead on size, valuation, profitability, growth and momentum. Global Health comes out ahead on financial health and technicals. Across the scored metrics below, Narayana Hrudayalaya leads on 12 and Global Health on 4. On StoxGud's 10-point checklist, Narayana Hrudayalaya scores 7/10 and Global Health scores 6/10.
| Metric | Narayana Hrudayalaya | Global Health |
|---|---|---|
| Size | ||
| Market cap | ₹38,890 Cr | ₹37,281 Cr |
| Revenue (latest FY) | ₹7,896 Cr | ₹4,410 Cr |
| Net profit (latest FY) | ₹806 Cr | ₹556 Cr |
| Valuation | ||
| P/E | 45.3 | 93.7 |
| P/B | 7.77 | 8.62 |
| Dividend yield | 0.23% | 0.04% |
| Profitability | ||
| Return on equity | 17.2% | 9.2% |
| Net profit margin | 8.4% | 7.9% |
| Operating margin | 18.5% | 22.1% |
| Growth | ||
| Revenue growth (YoY) | +73.0% | +33.6% |
| Net profit growth (YoY) | +16.5% | -100.0% |
| Revenue CAGR (multi-year) | +25.0% | +17.9% |
| Financial health | ||
| Debt to equity | 0.99 | 0.16 |
| Momentum | ||
| 1-month return | +10.4% | +7.2% |
| 1-year return | +5.7% | +0.9% |
| 3-year CAGR | +22.4% | +18.3% |
| 5-year CAGR | +28.5% | — |
| 10-year CAGR | +18.7% | — |
| Distance from 52W high | -8.5% | -8.0% |
| Technicals | ||
| RSI (14) | 71 | 71 |
| Price vs 200-day avg | +3.6% | +11.1% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Narayana Hrudayalaya | Global Health |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✗ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✓ | ✗ |
| Score | 7/10 | 6/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Narayana Hrudayalaya or Global Health?
Narayana Hrudayalaya has a market cap of ₹38,890 Cr and Global Health has a market cap of ₹37,281 Cr as of 06 Nov 2026.
Which has a lower P/E, Narayana Hrudayalaya or Global Health?
Narayana Hrudayalaya has the lower P/E: Narayana Hrudayalaya trades at 45.3 and Global Health at 93.7.
Which gave better returns in the last year, Narayana Hrudayalaya or Global Health?
Narayana Hrudayalaya did better: Narayana Hrudayalaya returned +5.7% and Global Health returned +0.9% over one year.
Is Narayana Hrudayalaya or Global Health a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Narayana Hrudayalaya scores 7/10 and Global Health scores 6/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.